Literature DB >> 16850757

Effects of PDTC on the proliferation and PCNA expression of human retinal pigment epithelial cells.

Jun Hu1, Guigang Li.   

Abstract

To investigate the effects of pyrrolidine dithiocarbamate (PDTC) on the proliferation and PCNA (proliferating cell nuclear antigen) expression of cultured human retinal pigment epithelium cells, human retinal pigment epithelium cells (RPE) were cultured from normal adults who, died accidentally. The effects of PDTC on the proliferation of RPE cells were examined by using methyl thiazlyl tetrazolium (MTT) assay. The effects of PDTC on the PCNA expression of RPE cells were immunohistochemically examined by employing biological image analysis system (BIAS). After treatment with PDTC of various of concentration ranging from 0.062 to 1 g/L for 24 h, or concentrations ranging from 0.031 to 1 g/L, the proliferation of RPE cells decreased in a dose-dependent manner. After treatment with PDTC of concentration varying from 0.062 to 1 g/L for 24 h, the PCNA expression was also suppressed in a dose-dependent manner. It is concluded that PDTC can inhibit the proliferation of RPE cells in vitro in a dose-and time-dependent manner, at least in part, by down-regulating the expression of PCNA. PDTC may be used to prevent and treat the proliferative vitreoretinopathy (PVR).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16850757     DOI: 10.1007/bf02895826

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  4 in total

Review 1.  Strategies to influence PVR development.

Authors:  Bernd Kirchhof
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-10       Impact factor: 3.117

2.  Ciprofloxacin and dexamethasone inhibit the proliferation of human retinal pigment epithelial cells in culture.

Authors:  C N Koutsandrea; M V Miceli; G A Peyman; H G Farahat; M R Niesman
Journal:  Curr Eye Res       Date:  1991-03       Impact factor: 2.424

3.  Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy.

Authors:  Maria Sydorova; Mun Seng Lee
Journal:  Ophthalmic Res       Date:  2005-06-29       Impact factor: 2.892

Review 4.  Growth regulation of the PCNA gene.

Authors:  R Baserga
Journal:  J Cell Sci       Date:  1991-04       Impact factor: 5.285

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.